Page last updated: 2024-08-21

glycidol and Histiocytic Sarcoma

glycidol has been researched along with Histiocytic Sarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies

Other Studies

1 other study(ies) available for glycidol and Histiocytic Sarcoma

Article	Year
Toxicology and carcinogenesis study of glycidol (CAS No. 556-52-5) in genetically modified haploinsufficient p16(Ink4a)/p19(Arf) mice (gavage study). National Toxicology Program genetically modified model report, 2007, Issue:13 Topics: Adenoma; Animals; Brain; Carcinogenicity Tests; Carcinogens; Cyclin-Dependent Kinase Inhibitor p16; Epoxy Compounds; Female; Histiocytic Sarcoma; Lung Neoplasms; Male; Mice; Mice, Transgenic; Neurons; Papilloma; Propanols; Stomach Neoplasms	2007

Article

Year

Toxicology and carcinogenesis study of glycidol (CAS No. 556-52-5) in genetically modified haploinsufficient p16(Ink4a)/p19(Arf) mice (gavage study).

National Toxicology Program genetically modified model report, 2007, Issue:13

Topics: Adenoma; Animals; Brain; Carcinogenicity Tests; Carcinogens; Cyclin-Dependent Kinase Inhibitor p16; Epoxy Compounds; Female; Histiocytic Sarcoma; Lung Neoplasms; Male; Mice; Mice, Transgenic; Neurons; Papilloma; Propanols; Stomach Neoplasms

2007